FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

9 letters match. Newest first.

  1. Central Coast Multispecialty Medical Group, Inc.

    FDA warns Central Coast Multispecialty Medical Group over incomplete donor screening and eligibility for reproductive tissue.

    High risk
  2. Conceive Fertility Center

    FDA says Conceive Fertility Center in Dallas used incomplete donor screening and testing for reproductive cells.

    High risk
  3. Louisville Reproductive Center

    Louisville Reproductive Center failed to properly test and screen semen donors for infectious diseases, FDA found.

    High risk
  4. Green Valley Fertility Partners

    FDA cited Green Valley Fertility Partners for donor eligibility failures involving oocyte HCT/Ps, including missing communicable disease testing and screening.

    High risk
  5. Sperm Bank, Inc. dba Fertility Center of California

    FDA warned Sperm Bank, Inc. dba Fertility Center of California over donor semen released without required infectious-disease testing and screening.

    High risk
  6. Akan Biosciences, Inc.

    FDA warned Akan Biosciences over unapproved Ayama injectable and donor-screening failures.

    High risk
  7. Mark S. Denker, M.D., PA dba Palm Beach Fertility Center

    FDA warns Boca Raton fertility center over failures to screen sperm and egg donors for infectious disease risk.

    High risk
  8. Cryos International USA LLC

    Cryos International USA released and distributed anonymous donor semen without required infectious disease testing and quarantine.

    High risk
  9. Cooper Institute

    FDA warned Houston fertility clinic Cooper Institute that it failed to test and screen oocyte donors for infectious diseases.

    High risk